IP Library Granted Patent US 12,540,348
Granted Patent B2
US 12,540,348 · App. 15/304,852 · Granted Feb 3, 2026

Device and methods of using device for detection of aminoacidopathies

Inventors: Omar Bilal Ayyub (Potomac, MD); Brian Theodore Heligman (North Potomac, MD); Peter Kofinas (North Bethesda, MD); Marshall Lynn Summar (Washington, DC); Juan Manuel Cabrera-Luque (Rockville, MD); Gary Cunningham (Washington, DC)
Assignees: University of Maryland, College Park; Children's National Medical Center
C12Q1/32B01L3/502715C12Q1/005G01N33/523G01N33/6812G01N33/6893B01L2200/10B01L2300/0887G01N2333/902G01N2333/904G01N2333/90622G01N2800/04G01N2800/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,540,348
App. No.
15/304,852
Granted
Feb 3, 2026
Kind
B2
Abstract

The present disclosure relates to a biosensor capable of measuring the total concentration of one or a plurality of amino acids with the use of a reaction surface comprising one or a plurality of metabolic enzymes or functional fragments thereof, but wherein the reaction surface does not comprise an electrode or electrically conductive support. In some embodiments, the biosensor comprises use of a thermophilic bacterial metabolic enzyme immobilized or attached to the reaction surface.

Claims (168)

1 . A biosensor comprising:

a light source;

a light detector comprising a complementary metal-oxide semiconductor (CMOS) or a charged-coupled device camera; and

one or more reaction surfaces comprising at least one oxidizing agent lyophilized or desiccated onto the one or more reaction surfaces, and one or more metabolic enzymes or functional fragments thereof;

wherein at least one of the one or more metabolic enzymes or functional fragments thereof is at least 80% homologous to a phenylalanine dehydrogenase from Geobacillus thermoglucosidasius;

wherein the one or more reaction surfaces do not comprise and are not attached to an electrically conductive support; and

wherein the one or more reaction surfaces are free of an electron mediator; and

wherein the light source is positioned at a distance from at least one of the one or more reaction surfaces sufficient to irradiate the at least one of the one or more reaction surfaces and the light detector is positioned at a distance from the one or more reaction surfaces sufficient to collect irradiated light from the one or more reaction surfaces, and

wherein the biosensor further comprises a housing that contains at least a first fluid opening adjacent to and in fluid communication with a filter paper immediately adjacent to a microfluidic chamber that comprises at least one of the one or more reaction surfaces.

2 . The biosensor of claim 1 , wherein at least one of the one or more reaction surfaces further comprises at least one circuit connecting the light detector to a controller.

3 . The biosensor of claim 1 , wherein at least one of the one or more reaction surfaces is a filter paper that comprises the one or more metabolic enzymes.

4 . The biosensor of claim 1 , wherein the one or more reaction surfaces are free of one or more of the following: (i) uricase or a functional fragment thereof; (ii) a hydrogel comprising dextran or a derivative thereof; (iii) a bacterial cell; (iv) an electronic dipole configured for electrophoresis; and (v) 3, 4,-dihydroxybenzoic acid (3, 4-DHB).

5 . The biosensor of claim 1 , wherein the biosensor is at least 70% biologically active after about thirty days in storage at 4 degrees Celsius.

6 . The biosensor of claim 1 , wherein at least one of the one or more reaction surfaces comprises a volume from about 10 uL to about 100 μL of fluid.

7 . The biosensor of claim 1 , wherein the biosensor is free of an electron mediator selected from: thionine, o-phenylenediamine, methylene blue, and toluidine blue.

8 . The biosensor of claim 1 , wherein the at least one oxidizing agent is chosen from: NAD+ or FAD+.

9 . The biosensor of claim 1 , wherein at least one of the one or more reaction surfaces consists of a filter paper comprising a mixture of at least one lyophilized metabolic enzyme or functional fragment thereof and a sugar at a concentration from about 100 mM to about 400 mM.

10 . The biosensor of claim 1 further comprising a hydrogel comprising alginate.

11 . The biosensor of claim 10 , wherein the alginate comprises a block polymer with a formula:

wherein m and n each are any positive integer.

12 . The biosensor of claim 1 , wherein the biosensor directly detects a reduction of the at least one oxidizing agent.

13 . The biosensor of claim 1 further comprising whole blood at the one or more reaction surfaces.

14 . The biosensor of claim 1 further comprising a Tris or glycine buffer in contact with the one or more metabolic enzymes or functional fragments thereof.

15 . The biosensor of claim 1 , wherein the biosensor is configured to compute a concentration of phenylalanine in a sample by comparing target data values to a calibration curve, the target data values captured by the light detector upon exposure of the sample to light by the light source, and the computation comprising:

determining a shortest distance from each target data value to a respective calibration point of the calibration curve, identifying two nearest points (d ks and d kss ) from the shortest distance from each target value to the respective calibration point, determining a concentration range (d c ) between the two nearest points, calculating a distance between x and y coordinates (d xy ) on a chromaticity space between the two nearest points, calculating a shortest distance from the space between the two nearest points to a line between the respective calibration points (d sd ), identifying d m as the largest of d ks , d kss , and d sd , calculating a variation (v+/−) as a ratio of (d m d c )/d xy , and determining a distance from one corresponding calibration point on the calibration curve to a point on a line where d sd is measured to arrive at the concentration of phenylalanine (Cm).

16 . The biosensor of claim 15 , wherein

the step of determining a shortest distance from each target data value to a respective calibration point of the calibration curve comprises calculating

d

k

=

(

x

k

-

x

)

2

+

(

y

k

-

y

)

2

,

where k is an integer from 1 to the number of stored x and y pairs (points) in the calibration curve, the step of determining a concentration range (de) between the two nearest points comprises calculating d C =|C ks −C kss , where C ks and C kss are the concentrations of the points corresponding to d ks and d kss ,

the step of calculating a distance between x and y coordinates (d xy ) on a chromaticity space between the two nearest points comprises calculating

d

xy

=

(

x

ks

-

x

kss

)

2

+

(

y

ks

-

γ

kss

)

2

,

the step of calculating a shortest distance from the space between the two nearest points to a line between the respective calibration points (d sd ) comprises calculating

d

s

d

=

"\[LeftBracketingBar]"

(

x

kss

-

x

ks

)

(

y

ks

-

y

m

)

-

(

x

kss

-

x

m

)

(

y

ks

-

y

kss

)

"\[RightBracketingBar]"

(

x

ss

-

x

ks

)

2

+

(

y

kss

-

y

ks

)

2

,

and

the step of determining a distance from one corresponding calibration point on the calibration curve to a point on a line where d sd is measured to arrive at the concentration of phenylalanine (Cm) comprises calculating

C

m

=

d

p

d

c

d

xy

,

where

d

p

=

d

ks

2

-

d

sd

2

.

17 . A system comprising the biosensor of claim 1 and a computer processor in operable connection to at least one computer storage memory.

18 . The system of claim 17 , further comprising:

a digital display in operable connection to the light detector by an electrical circuit capable of carrying an electrical signal corresponding to a measurement of irradiated light from at least one of the one or more reaction surfaces to the digital display,

wherein the digital display is configured to display concentration value of an amino acid in a sample when the light detector collects irradiated light from the at least one of the one or more reaction surfaces after a time period sufficient for the at least one metabolic enzyme to catalyze the oxidation of its amino acid substrate at the at least one of the one or more reaction surfaces.

19 . The system of claim 17 , wherein the at least one of the one or more metabolic enzymes or functional fragments thereof that is at least 80% homologous to a phenylalanine dehydrogenase from Geobacillus thermoglucosidasius is immobilized to at least one of the one or more reaction surfaces with one or a plurality of sugar molecules.

20 . A kit comprising (i) the biosensor of claim 1 ; and (ii) a set of instructions optionally accessible remotely through an electronic medium;

wherein at least one of the one or more reaction surfaces comprises a test strip or filter paper contained within a removable housing having at least one fluid inlet.

21 . A method of quantifying a concentration of one or more amino acids in sample of bodily fluid of a subject comprising contacting a sample of bodily fluid to the biosensor of claim 1 ; and exposing the sample of bodily fluid to light emitted from the light source of the biosensor prior to detecting the light emitted from the one or more reaction surfaces of the biosensor.

22 . The method of claim 21 , wherein the step of contacting comprises exposing the sample of bodily fluid of a subject to the one or more reaction surfaces of the biosensor for a time period sufficient to allow oxidation of at least one amino acid in the sample of bodily fluid by the one or more metabolic enzymes or functional fragments thereof of the biosensor.

23 . The method of claim 21 , wherein the sample of bodily fluid contains whole blood or serum from a subject.

24 . A method of diagnosing a metabolic disease in a subject comprising: contacting a sample of bodily fluid to the biosensor of claim 1 ;

quantifying one or more concentration values of amino acids in the sample using the biosensor;

comparing the one or more concentration values of amino acids in the sample to a threshold value of amino acid concentration identified as being in a healthy range; and identifying the subject as having a metabolic disease if the one or more concentration values of amino acids in the sample exceed or fall below the threshold value.

25 . The method of claim 24 , wherein the metabolic disease is chosen from at least one or a combination of: phenylketonuria, hyperammonemia, and maple syrup urine disease.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2025
From: SUMMAR, MARSHALL LYNN; CABRERA-LUQUE, JUAN MANUEL; CUNNINGHAM, GARY
To: CHILDREN'S NATIONAL MEDICAL CENTER
Reel/Frame 073306/0389 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED ON REEL 42542 FRAME 15. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 23, 2025
From: AYYUB, OMAR; KOFINAS, PETER; HELIGMAN, BRIAN
To: UNIVERSITY OF MARYLAND, COLLEGE PARK
Reel/Frame 074050/0676 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2017
From: AYYUB, OMAR; KOFINAS, PETER; HELIGMAN, BRIAN
To: UNIVERSITY OF MARYLAND
Reel/Frame 042542/0015 →
Continuity (3)
Provisional Application 62112019 · Feb 4, 2015
Provisional Application 61981126 · Apr 17, 2014
Related Publication 20170198329A1 · Jul 13, 2017
References Cited (82)
US 4254222A · Owen · 1981 [cited by applicant]
US 4351899A · Owen · 1982 [cited by applicant]
US 4806343A · Carpenter · 1989 [cited by examiner]
US 4849345A · Asano · 1989 [cited by examiner]
US 4963814A · Parks et al. · 1990 [cited by applicant]
US 4966856A · Ito · 1990 [cited by examiner]
US 4999582A · Parks et al. · 1991 [cited by applicant]
US 4999632A · Parks · 1991 [cited by applicant]
US 5041733A · Noguchi · 1991 [cited by examiner]
US 5243516A · White · 1993 [cited by applicant]
US 5326697A · Magers · 1994 [cited by applicant]
US 5353351A · Bartoli et al. · 1994 [cited by applicant]
US 5366609A · White et al. · 1994 [cited by applicant]
US 5405511A · White et al. · 1995 [cited by applicant]
US 5438271A · White et al. · 1995 [cited by applicant]
US 5510245A · Magers · 1996 [cited by applicant]
US 5670031A · Hintsche et al. · 1997 [cited by applicant]
US 5762770A · Pritchard et al. · 1998 [cited by applicant]
US 5912139A · Iwata et al. · 1999 [cited by applicant]
US 5969813A · Hammond · 1999 [cited by examiner]
US 6200773B1 · Ouyang et al. · 2001 [cited by applicant]
US 6541216B1 · Wilsey et al. · 2003 [cited by applicant]
US 6645359B1 · Bhullar et al. · 2003 [cited by applicant]
US 6662439B1 · Bhullar · 2003 [cited by applicant]
US 6696266B1 · Etoh · 2004 [cited by examiner]
US 6736957B1 · Forrow et al. · 2004 [cited by applicant]
US 20010053849A1 · Kreek · 2001 [cited by examiner]
US 20020127623A1 · Minshull et al. · 2002 [cited by applicant]
US 20030092034A1 · Cooper · 2003 [cited by examiner]
US 20030176183A1 · Drucker et al. · 2003 [cited by applicant]
US 20040043376A1 · Gupta · 2004 [cited by examiner]
US 20060223729A1 · Hamblin · 2006 [cited by examiner]
US 20070077567A1 · Kim et al. · 2007 [cited by applicant]
US 20070112118A1 · Park · 2007 [cited by examiner]
US 20070122867A1 · Shunnarah · 2007 [cited by examiner]
US 20080045825A1 · Melker et al. · 2008 [cited by applicant]
US 20080242738A1 · Marks et al. · 2008 [cited by applicant]
US 20080262321A1 · Erad · 2008 [cited by examiner]
US 20120129710A1 · Mccafferty et al. · 2012 [cited by applicant]
US 20120164627A1 · Battrell et al. · 2012 [cited by applicant]
US 20120231489A1 · Lenhert · 2012 [cited by applicant]
US 20130081958A1 · Jung · 2013 [cited by examiner]
US 20130201049A1 · Sugimoto · 2013 [cited by applicant]
US 20150299760A1 · Hovda · 2015 [cited by examiner]
EP 1314786A1 · 2003 [cited by examiner]
JP H1033196A · 1998 [cited by applicant]
JP 2003065951A · 2003 [cited by applicant]
JP 2006271379A · 2006 [cited by applicant]
JP 2006524509A · 2006 [cited by applicant]
JP 2009168671A · 2009 [cited by applicant]
JP 2012020054A · 2012 [cited by applicant]
WO WO0218624A1 · 2002 [cited by applicant]
WO 03025627A2 · 2003 [cited by applicant]
WO WO2004091376A2 · 2004 [cited by applicant]
WO WO2008029920A1 · 2008 [cited by examiner]
WO WO2014062985A1 · 2014 [cited by examiner]
“Microcomputer.” Britannica Academic, Encyclopaedia Britannica. Published May 12, 2016. [online]. [Retrieved on Sep. 2, 2018]. URL: <http://academic.eb.com/levels/collegiate/article/microcomputer/52500>. (Year: 2016). [cited by examiner]
Takada, H et al. Thermostable phenyalanine dehydrogenase of Thermoactinomyces intermedius: cloning, expression, and sequencing of its gene. J. Biochem. 1991. 109: 371-376. (Year: 1991). [cited by examiner]
Hay, ID et al. Microbial alginate production, modification and its applications. Microbial Biotechnology. 2013. 6: 637-650. (Year: 2013). [cited by examiner]
Villalonga, R et al. Increased conformational and thermal stability properties for phenyalanine dehydrogenase by chemical glycosidation with end-group activated dextran. Biotechnology Letters. 2005. 27: 1311-1317. (Year… [cited by examiner]
Azmi, NE et al. An optical based biosensor for the determination of ammonium in aqueous environment. American Journal of Analytical Chemistry. 2012. 3: 364-370. (Year: 2012). [cited by examiner]
Arakawa, T et al. Biosensor for L-phenylalanine based on the optical detection of NADH using a UV light emitting diode. Microchim Acta. 2011. 173: 199-205. (Year: 2011). [cited by examiner]
Ayyub, OB et al. Point of care sensing of phenylketonuria. J. Inherit. Metab. Dis. 2013. 36(Suppl 2): S136. Abstract P-079. Published Aug. 8, 2013. (Year: 2013). [cited by examiner]
Ali Kemal Yetisen et al: “Paper-based microfluidic point-of-care diagnostic devices” Lab on a Chip, vol. 13, No. 12, Jan. 1, 2013 (pp. 2210-2251), XP055105962. [cited by applicant]
Nuno Pires et al: “Recent Developments in Optical Detection Technologies in Lab-on-a-Chip Devices . . . ”, Sensors, vol. 14, No. 8, Aug. 21, 2014, pp. 15458-15479, XP055413471. [cited by applicant]
Tomoyuki Koshida et al: “Fluorescence biosensing system . . . , Sensors and Actuators B: Chemical: International Journal . . . ”, vol. 146, No. 1, Apr. 8, 2010, pp. 177-182. [cited by applicant]
Gregory Thiessen et al: “Conversion of a laboratory-based test for phenylalanine detection to a simple . . . ”, Analyst, vol. 140, No. 2, Nov. 26, 2014, pp. 609-615. [cited by applicant]
Weiss et al., Dehydrogenase based reagentless biosensor for monitoring phenylketonuria, [cited by applicant]
Uniprot F8CXT3 , [cited by applicant]
Forrow et al., Development of a commercial amperometric biosensor electrode for the ketone D-3-hydroxybutyrate, [cited by applicant]
Azmi et al., Biosensor based on glutamate dehydrogenase immobilized in chitosan for the determination of ammonium in water samples, [cited by applicant]
Cui et al., Development of an interference-free biosensor for I-glutamate using a bienzyme salicylate hydroxylase/I-glutamate dehydrogenase system, Enzyme and Microbial Tech 2007;41(6-7):689-693. [cited by applicant]
Huang et al., Determination of L-phenylalanine based on an NADH-detecting biosensor, [cited by applicant]
Ionescue et al., Improved enzyme retention from an electroploymerized polypyrrole-alginate matrix in the development of biosensors, [cited by applicant]
Kwan et al., Amperometric determination of ammonium with bienzyme/poly(carbamoyl) sulfonate hydrogel-based biosensor, [cited by applicant]
Qin et al., Amperometric enzyme electrodes of glucose and lactate based on poly(diallyldimethylammonium)-alginate-metal ion-enzyme biocomposites, [cited by applicant]
Villalonga et al., Supramolecular-mediated immobilization of L-phenylalanine dehydrogenase on cyclodextrin-coated Au electrodes for biosensor application, Biotech Letters 2007; 29(3); 447-452. [cited by applicant]
Jeffries C et al: “Evaluation of a thermophile enzyme for a carbon paste amperometric biosensor: L-glutamate dehydrogenase”, Biosensors and Bioelectronics (1997) vol. 12, No. 3, 1997, pp. 225-232. [cited by applicant]
Pasco N et al: “Characterisation of a thermophilic L-glutamate dehydrogenase biosensor for amperometric determination of L-glutamate by flow injection analysis.”, Biosensors & Bioelectronics (1999), vol. 14, No. 2, pp. … [cited by applicant]
Communication pursuant to Article 94(3) EPC was issued on May 28, 2019 by the European Patent Office for EP Application No. 13846569.5, which was filed on Oct. 17, 2013 and published as EP 2909606 on Aug. 26, 2015 (Appl… [cited by applicant]
International Search Report and Written Opinion of the International Searching Authority for PCT/US2015/026546 Mailed Aug. 14, 2015. [cited by applicant]
International Preliminary Report on Patentability for PCT/US2015/026546 Issued Oct. 18, 2016. [cited by applicant]